DK115489A - Foerfoedselscreening for down's syndrom - Google Patents
Foerfoedselscreening for down's syndromInfo
- Publication number
- DK115489A DK115489A DK115489A DK115489A DK115489A DK 115489 A DK115489 A DK 115489A DK 115489 A DK115489 A DK 115489A DK 115489 A DK115489 A DK 115489A DK 115489 A DK115489 A DK 115489A
- Authority
- DK
- Denmark
- Prior art keywords
- syndrome
- alpha
- dheas
- hydroxy
- dehydroepiandrosterone sulphate
- Prior art date
Links
- 201000010374 Down Syndrome Diseases 0.000 title abstract 3
- 206010044688 Trisomy 21 Diseases 0.000 title abstract 3
- 238000012216 screening Methods 0.000 title abstract 2
- 229950009829 prasterone sulfate Drugs 0.000 abstract 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 abstract 2
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 1
- QQIVKFZWLZJXJT-UHFFFAOYSA-N (3alpha,16alpha)-3,16-Dihydroxyandrost-5-en-17-one Natural products C1C(O)CCC2(C)C3CCC(C)(C(C(O)C4)=O)C4C3CC=C21 QQIVKFZWLZJXJT-UHFFFAOYSA-N 0.000 abstract 1
- QQIVKFZWLZJXJT-DNKQKWOHSA-N 16alpha-hydroxydehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C([C@H](O)C4)=O)[C@@H]4[C@@H]3CC=C21 QQIVKFZWLZJXJT-DNKQKWOHSA-N 0.000 abstract 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 abstract 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 1
- 230000008774 maternal effect Effects 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 229960003387 progesterone Drugs 0.000 abstract 1
- 239000000186 progesterone Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/385—Congenital anomalies
- G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Holo Graphy (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878716158A GB8716158D0 (en) | 1987-07-09 | 1987-07-09 | Antenatal screening for down's syndrome |
| GB8716158 | 1987-07-09 | ||
| GB8724913 | 1987-10-23 | ||
| GB878724913A GB8724913D0 (en) | 1987-10-23 | 1987-10-23 | Antenatal screening for down's syndrome |
| PCT/GB1988/000557 WO1989000696A1 (en) | 1987-07-09 | 1988-07-11 | Antenatal screening for down's syndrome |
| GB8800557 | 1988-07-11 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK115489D0 DK115489D0 (da) | 1989-03-09 |
| DK115489A true DK115489A (da) | 1989-05-09 |
| DK172477B1 DK172477B1 (da) | 1998-09-14 |
Family
ID=26292455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198901154A DK172477B1 (da) | 1987-07-09 | 1989-03-09 | Fremgangsmåde til bestemmelse af risiko af Down's syndrom og analysemidler til anvendelse derved |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0362294B1 (da) |
| JP (1) | JP2525474B2 (da) |
| AT (1) | ATE91182T1 (da) |
| DE (1) | DE3882140T2 (da) |
| DK (1) | DK172477B1 (da) |
| WO (1) | WO1989000696A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0666477B1 (en) * | 1989-01-17 | 2003-10-15 | JN Macri Technologies LLC, Inc. | Apparatus for detecting Down syndrome by non-invasive maternal blood screening |
| US5252489A (en) * | 1989-01-17 | 1993-10-12 | Macri James N | Down syndrome screening method utilizing dried blood samples |
| US5258907A (en) * | 1989-01-17 | 1993-11-02 | Macri James N | Method and apparatus for detecting down syndrome by non-invasive maternal blood screening |
| US5324667A (en) * | 1989-01-17 | 1994-06-28 | Macri James N | Method for detecting down sydrown by non-invasive maternal blood screening |
| GB9224965D0 (en) * | 1992-11-28 | 1993-01-20 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
| GB9306354D0 (en) * | 1993-03-26 | 1993-05-19 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
| GB9315230D0 (en) * | 1993-07-22 | 1993-09-08 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
| US5583612A (en) * | 1994-07-14 | 1996-12-10 | Xerox Corporation | Flexible latch with relaxed engagement |
| GB9416415D0 (en) * | 1994-08-13 | 1994-10-05 | Kodak Ltd | Antenatel screening for pregnacy abnormalities |
| GB9606261D0 (en) * | 1996-03-25 | 1996-05-29 | Johnson & Johnson Clin Diag | Prenatal screening for fetal abnormalities |
| KR100459271B1 (ko) * | 2002-04-26 | 2004-12-03 | 엘지.필립스 엘시디 주식회사 | 구리 단일막 또는 구리 몰리브덴막의 식각용액 및 그식각방법 |
| WO2012049874A1 (ja) * | 2010-10-13 | 2012-04-19 | ヒューマン・メタボローム・テクノロジーズ株式会社 | 脂肪性肝疾患を診断するためのバイオマーカー、その測定方法、コンピュータプログラム、および、記憶媒体 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454232A (en) * | 1982-06-07 | 1984-06-12 | Bio-Rad Laboratories, Inc. | Estriol assay |
| GR850899B (da) * | 1984-04-12 | 1985-11-25 | Gen Hospital Corp | |
| US4670401A (en) * | 1985-01-25 | 1987-06-02 | Monell Chemical Senses Center | Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators |
-
1988
- 1988-07-11 AT AT88905972T patent/ATE91182T1/de not_active IP Right Cessation
- 1988-07-11 WO PCT/GB1988/000557 patent/WO1989000696A1/en not_active Ceased
- 1988-07-11 EP EP88905972A patent/EP0362294B1/en not_active Expired - Lifetime
- 1988-07-11 DE DE88905972T patent/DE3882140T2/de not_active Expired - Lifetime
- 1988-07-11 JP JP63505897A patent/JP2525474B2/ja not_active Expired - Lifetime
-
1989
- 1989-03-09 DK DK198901154A patent/DK172477B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3882140T2 (de) | 1993-12-23 |
| EP0362294A1 (en) | 1990-04-11 |
| JPH03502483A (ja) | 1991-06-06 |
| JP2525474B2 (ja) | 1996-08-21 |
| DK115489D0 (da) | 1989-03-09 |
| ATE91182T1 (de) | 1993-07-15 |
| DE3882140D1 (en) | 1993-08-05 |
| WO1989000696A1 (en) | 1989-01-26 |
| EP0362294B1 (en) | 1993-06-30 |
| DK172477B1 (da) | 1998-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tulppala et al. | Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women | |
| Krantz et al. | First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency | |
| US7892774B2 (en) | Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor | |
| DK115489D0 (da) | Foerfoedselscreening for down's syndrom | |
| IL139302A0 (en) | Antenatal screening for down's syndrome | |
| EP0316919A3 (en) | Vaginal sample test and reagents | |
| ATE412896T1 (de) | Pränatales down-syndrom-testverfahren unter benutzung von hyperglykosyliertem gonadotropin | |
| IE44204L (en) | Reagent for pregnancy testing | |
| DK0409956T3 (da) | Downs syndrom-screeningmetode | |
| Dumps et al. | Accuracy of single measurements of pregnancy-associated plasma protein-A, human chorionic gonadotropin and progesterone in the diagnosis of early pregnancy failure | |
| ATE163971T1 (de) | Verfahren zur isolierung von fetalen zytotrophoblastzellen | |
| Houghton et al. | Relationship of maternal and fetal levels of human placental lactogen to the weight and sex of the fetus | |
| ATE227024T1 (de) | Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut | |
| DE69525400D1 (de) | Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten | |
| Andersen | Concentrations of free oestradiol and progesterone in human preovulatory follicular fluid | |
| Loncar et al. | Advent of maternal serum markers for Down syndrome screening | |
| Johnson et al. | The role of trophoblast dysfunction in the aetiology of miscarriage | |
| Garau et al. | Estrogen and progesterone receptor assays on the vulvar epithelium | |
| Spencer | Is the measurement of unconjugated oestriol of value in screening for Down’s syndrome | |
| JP3440138B2 (ja) | 染色体異常について妊娠期間中にスクリーニングするための方法および装置 | |
| Seki et al. | Correlation between urinary oestrogen levels determined by haemagglutination inhibition reaction and serum oestradiol levels determined by radioimmunoassay | |
| Chatzakis et al. | Dramatic increase in levels of placental protein 14 in amniotic fluid at 10–15 weeks' pregnancy | |
| AHMED et al. | Determination of the stage of gestation by the assay of chorionic gonadotrophin and Schwangerschaftsprotein 1 | |
| Grudzinskas | Biochemical screening for down syndrome: A workshop report | |
| UA41203A (uk) | Спосіб прогнозування невиношування вагітності в ранніх термінах |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |